Free Account Opening + AMC Free Demat
Loading...

Chemplast Sanmar IPO vs Windlas Biotech IPO

Comparision between Chemplast Sanmar IPO and Windlas Biotech IPO.

IPO Details

Chemplast Sanmar IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Windlas Biotech IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

Issue Size and Price

The total issue size of Chemplast Sanmar IPO is up to ₹3,850.00 Cr whereas the issue size of the Windlas Biotech IPO is up to ₹401.54 Cr. The final issue price of Chemplast Sanmar IPO is ₹541.00 per share and of Windlas Biotech IPO is ₹460.00 per share.

  Chemplast Sanmar IPO Windlas Biotech IPO
Face Value ₹5 per share ₹5 per share
Issue Price (Lower) ₹530.00 per share ₹448.00 per share
Issue Price (Upper) ₹541.00 per share ₹460.00 per share
Issue Price (Final) ₹541.00 per share ₹460.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 27 shares 30 shares
Fresh Issue Size
Fresh Issue Size (Amount) up to ₹1,300.00 Cr up to ₹165.00 Cr
OFS Issue Size 51,42,067 shares
OFS Issue Size (Amount) up to ₹2,550.00 Cr up to ₹236.54 Cr
Issue Size Total
Issue Size Total (Amount) up to ₹3,850.00 Cr up to ₹401.54 Cr

IPO Timetable

Chemplast Sanmar IPO opens on Aug 10, 2021, while Windlas Biotech IPO opens on Aug 04, 2021. The closing date of Chemplast Sanmar IPO and Windlas Biotech IPO is Aug 12, 2021, and Aug 06, 2021, respectively.

  Chemplast Sanmar IPO Windlas Biotech IPO
Anchor Bid Date
Issue Open Aug 10, 2021 Aug 04, 2021
Issue Close Aug 12, 2021 Aug 06, 2021
Basis Of Allotment (Tentative) Aug 18, 2021 Aug 11, 2021
Initiation of Refunds (Tentative) Aug 20, 2021 Aug 12, 2021
Credit of Share (Tentative) Aug 23, 2021 Aug 13, 2021
Listing date (Tentative) Aug 24, 2021 Aug 16, 2021
Anchor Lockin End date 1 Sep 17, 2021 Sep 10, 2021
Anchor Lockin End date 2 Nov 16, 2021 Nov 09, 2021

Financials

Chemplast Sanmar IPO P/E ratio is , as compared to Windlas Biotech IPO P/E ratio of .

  Chemplast Sanmar IPO Windlas Biotech IPO
Financial
Summary of financial Information (Restated Consolidated)
Particulars For the year/period ended (₹ in million)
31-Mar-21 31-Mar-20 31-Mar-19
Total Assets 44,860.93 41,075.40 38,015.63
Total Revenue 38,151.08 12,655.10 12,667.74
Profit After Tax 4,102.44 461.25 1184.64
Summary of financial Information (Restated Consolidated)
Particulars For the year/period ended (₹ in million)
31-Mar-21 31-Mar-20 31-Mar-19
Total Assets 2,961.23 3,384.88 2,981.80
Total Revenue 4,306.95 3,313.39 3,115.25
Profit After Tax 155.70 162.13 638.22
Promoter Shareholding (Pre-Issue) 100% 78%
Promoter Shareholding (Post-Issue) 54.99% 65.16%
P/E Ratio
Market Cap
ROE
ROCE
Debt/Equity
EPS
RoNW

Shares Offered

In the Chemplast Sanmar IPO retail investors (RII) are offered 72,64,150 shares while in Windlas Biotech IPO retail investors are offered 72,64,150 shares. Qualified institutional buyers (QIB) are offered 2,17,92,453 shares in Chemplast Sanmar IPO and 17,23,700 shares in Windlas Biotech IPO.

  Chemplast Sanmar IPO Windlas Biotech IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB 2,17,92,453 shares 17,23,700 shares
NII 1,08,96,226 shares 13,23,766 shares
RII 72,64,150 shares 30,88,786 shares
Employee 0 shares 0 shares
Others
Total 3,99,52,829 shares 61,36,252 shares

Bids Received (Subscription)

Chemplast Sanmar IPO subscribed 2.17x in total, whereas Windlas Biotech IPO subscribed 22.44x.

  Chemplast Sanmar IPO Windlas Biotech IPO
QIB (times) 2.70x 24.40x
NII (times) 1.03x 15.73x
Big NII (times)
Small NII (times)
RII (times) 2.29x 24.22x
Employee (times)
Other (times)
Total (times) 2.17x 22.44x

Comments

Add a public comment...